Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.

Subjects

Subjects :

Antibodies, Monoclonal, Humanized adverse effects
Antineoplastic Combined Chemotherapy Protocols
Humans
Acute Kidney Injury chemically induced
Acute Kidney Injury diagnosis
Lung Neoplasms drug therapy

Details

Language :

English

ISSN :

1523-1755

Volume :

102

Issue :

4

Database :

MEDLINE

Journal :

Kidney international

Publication Type :

Academic Journal

Accession number :

35964800

Full Text :

https://doi.org/10.1016/j.kint.2022.07.019